Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia

Working, 1996, Pharmacological–toxicological expert report — Caelyx(TM) – (Stealth(R) liposomal doxorubicin HCl) — Foreword, Hum. Exp. Toxicol., 15, 751 Gabizon, 2003, Pharmacokinetics of pegylated liposomal doxorubicin — review of animal and human studies, Clin. Pharmacokinet., 42, 419, 10.2165/00003088-200342050-00002 Gabizon, 1992, Selective tumor-localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes, Cancer Res., 52, 891 Northfelt, 1996, Doxorubicin encapsulated in liposomes containing surface-found polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma, J. Clin. Pharmacol., 36, 55, 10.1002/j.1552-4604.1996.tb04152.x Ten Hagen, 2002, Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, Int. J. Cancer, 97, 115, 10.1002/ijc.1578 Gabizon, 1994, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes, Cancer Res., 54, 987 Yatvin, 1978, Design of liposomes for enhanced local release of drugs by hyperthermia, Science, 202, 1290, 10.1126/science.364652 Mayhew, 1992, Pharmacokinetics and antitumor-activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid, Int. J. Cancer, 51, 302, 10.1002/ijc.2910510221 Dvorak, 1995, Vascular-permeability factor vascular endothelial growth-factor, microvascular hyperpermeability, and angiogenesis, Am. J. Pathol., 146, 1029 Yuan, 1995, Vascular-permeability in a human tumor xenograft — molecular-size dependence and cutoff size, Cancer Res., 55, 3752 Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Charrois, 2003, Rate of biodistribution of STEALTH((R)) liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity, Biochim. Biophys. Acta, Biomembr., 1609, 102, 10.1016/S0005-2736(02)00661-2 Gaber, 1996, Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks, Int. J. Radiat. Oncol. Biol. Phys., 36, 1177, 10.1016/S0360-3016(96)00389-6 Kong, 2001, Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature, Cancer Res., 61, 3027 Anyarambhatla, 1999, Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: a new temperature-sensitive liposome for use with mild hyperthermia, J. Liposome Res., 9, 491, 10.3109/08982109909035549 Tsong, 1974, Kinetics of the crystalline-liquid crystalline phase transition of dimyristoyl L-alpha-lecithin bilayers, Proc. Natl. Acad. Sci. U. S. A., 71, 2684, 10.1073/pnas.71.7.2684 Allen, 1991, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta, 1066, 29, 10.1016/0005-2736(91)90246-5 Papahadjopoulos, 1991, Sterically stabilized liposomes — improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad. Sci. U. S. A., 88, 11460, 10.1073/pnas.88.24.11460 Nicholas, 2000, Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles, Biochim. Biophys. Acta, Biomembr., 1463, 167, 10.1016/S0005-2736(99)00192-3 Kenworthy, 1995, Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol), Biophys. J., 68, 1921, 10.1016/S0006-3495(95)80369-3 deGennes, 1987, Polymers at an interface: a simplified view, Adv. Colloid Interface Sci., 27, 189, 10.1016/0001-8686(87)85003-0 Kenworthy, 1995, Structure and phase-behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol), Biophys. J., 68, 1903, 10.1016/S0006-3495(95)80368-1 Yoshioka, 1991, Surface modification of hemoglobin-containing liposomes with polyethylene-glycol prevents liposome aggregation in blood-plasma, Biomaterials, 12, 861, 10.1016/0142-9612(91)90075-L Belsito, 2001, Lipid chain length effect on the phase behaviour of PCs/PEG : 2000-PEs mixtures. A spin label electron spin resonance and spectrophotometric study, Biophys. Chemist., 93, 11, 10.1016/S0301-4622(01)00201-0 Edwards, 1997, Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes, Biophys. J., 73, 258, 10.1016/S0006-3495(97)78066-4 Ickenstein, 2003, Disc formation in cholesterol-free lippsornes during phase transition, Biochim. Biophys. Acta, Biomembr., 1614, 135, 10.1016/S0005-2736(03)00196-2 Allen, 1994, Long-circulating (sterically stabilized) liposomes for targeted drug-delivery, Trends Pharmacol. Sci., 15, 215, 10.1016/0165-6147(94)90314-X Hossann, 2007, In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes, Biochim. Biophys. Acta, Biomembr., 1768, 2491, 10.1016/j.bbamem.2007.05.021 Lasic, 1993, 63 Rouser, 1970, Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots, Lipids, 5, 494, 10.1007/BF02531316 Mabrey, 1976, Investigation of phase transitions of lipids and lipid mixtures by high sensitivity differential scanning calorimetry, Proc. Natl. Acad. Sci. U. S. A., 73, 3862, 10.1073/pnas.73.11.3862 Seynhaeve, 2007, Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response, Cancer Res., 67, 9455, 10.1158/0008-5472.CAN-07-1599 Papenfuss, 1979, A transparent access chamber for the rat dorsal skin fold, Microvasc. Res., 18, 311, 10.1016/0026-2862(79)90039-6 Needham, 2000, A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model, Cancer Res., 60, 1197 Hauck, 2006, Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors, Clin. Cancer Res., 12, 4004, 10.1158/1078-0432.CCR-06-0226 Nikolova, 1998, Phospholipid free thin liquid films with grafted poly(ethylene glycol)-2000: formation, interaction forces and phase states, Biochim. Biophys. Acta, Biomembr., 1372, 237, 10.1016/S0005-2736(98)00061-3 Gaber, 1995, Thermosensitive sterically stabilized liposomes — formulation and in-vitro studies on mechanism of doxorubicin release by bovine serum and human plasma, Pharm. Res., 12, 1407, 10.1023/A:1016206631006 Kong, 2000, Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size, Cancer Res., 60, 4440 Lindner, 2004, Novel temperature-sensitive liposomes with prolonged circulation time, Clin. Cancer Res., 10, 2168, 10.1158/1078-0432.CCR-03-0035